Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study
暂无分享,去创建一个
B. Conway | M. Hellard | G. Dore | J. Amin | M. Weltman | G. Foster | D. Shaw | A. Dunlop | J. Bruneau | J. Grebely | S. Bourgeois | P. Bruggmann | B. Hajarizadeh | P. Marks | T. Applegate | E. Cunningham | O. Dalgard | Sophie Quiene | T. Swan | M. C. Thurnheer | G. Robaeys | H. Midgard | M. Backmund